Verification evidence is still being completed.
PDF / print export
3B Pharmaceuticals
Berlin, Germany
- Verified lead
- Ulrich Haagmann
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Radiopharmaceuticals, Oncology, Peptide Therapeutics, Companion Diagnostics, and Drug Development
- Review cycle
- May 2026
- Full address
- Magnusstrasse 11, 12489 Berlin, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official 3B Pharmaceuticals contact page confirming the Berlin address.
- Editorial note
- 3B Pharmaceuticals is published because official company materials confirm current leadership, Berlin operating address, and a real radiopharmaceutical therapeutics platform.
Radiopharmaceuticals, Oncology, Peptide Therapeutics, Companion Diagnostics, and Drug Development
Official leadership disclosure, Official Berlin address disclosure, Radiopharmaceutical platform claim
3B Pharmaceuticals is published because official company materials confirm current leadership, Berlin operating address, and a real radiopharmaceutical therapeutics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Berlin, Germany
3B Pharmaceuticals
Radiopharmaceuticals, Oncology, Peptide Therapeutics, Companion Diagnostics, and Drug Development · Development-stage radiopharma platform
3B Pharmaceuticals runs radiopharmaceutical development, peptide therapeutics programs, and oncology translation work in Berlin, Germany.
- Lead
- Ulrich Haagmann (verified ↗)
- Address
- Magnusstrasse 11, 12489 Berlin, Germany (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Development-stage radiopharma platform
- Capabilities
- Radiopharmaceutical Development · Peptide Therapeutics Programs · Oncology Translation Work
- Founded
- 2003
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Ulrich Haagmann
Chief Executive Officer
Full addressMagnusstrasse 11, 12489 Berlin, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Development-stage radiopharma platform
Berlin, Germany. Radiopharmaceuticals, Oncology, Peptide Therapeutics, Companion Diagnostics, and Drug Development. Review completed on 22 Mar 2026.
German corporate and radiopharmaceutical oversight
Official leadership disclosure, Official Berlin address disclosure, Radiopharmaceutical platform claim
Radiopharmaceuticals, Oncology, Peptide Therapeutics, Companion Diagnostics, and Drug Development
3B Pharmaceuticals is published because official company materials confirm current leadership, Berlin operating address, and a real radiopharmaceutical therapeutics platform.
Editorial note
3B Pharmaceuticals is published because official company materials confirm current leadership, Berlin operating address, and a real radiopharmaceutical therapeutics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Radiopharmaceutical Development
Peptide Therapeutics Programs
Oncology Translation Work
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Peptide-discovery workflow
Radiopharmaceutical R&D infrastructure
Oncology development systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is 3B Pharmaceuticals located?
- 3B Pharmaceuticals operates from Magnusstrasse 11, 12489 Berlin, Germany, Berlin, Germany.
- Who runs 3B Pharmaceuticals?
- 3B Pharmaceuticals is led by Ulrich Haagmann, Chief Executive Officer. Verified 22 Mar 2026.
- What does 3B Pharmaceuticals do?
- 3B Pharmaceuticals runs radiopharmaceutical development, peptide therapeutics programs, and oncology translation work in Berlin, Germany. Core capabilities: Radiopharmaceutical Development, Peptide Therapeutics Programs, Oncology Translation Work.
Editorial context
Related technical briefs
Briefs that name Berlin as a covered market or city.